GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (MEX:BMRN) » Definitions » E10

Biomarin Pharmaceutical (MEX:BMRN) E10 : MXN-20.69 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Biomarin Pharmaceutical E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biomarin Pharmaceutical's adjusted earnings per share data for the three months ended in Dec. 2024 was MXN13.348. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-20.69 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was 17.60% per year. During the past 5 years, the average E10 Growth Rate was 11.10% per year. During the past 10 years, the average E10 Growth Rate was -11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biomarin Pharmaceutical was 20.60% per year. The lowest was -63.90% per year. And the median was 6.25% per year.

As of today (2025-03-23), Biomarin Pharmaceutical's current stock price is MXN1480.00. Biomarin Pharmaceutical's E10 for the quarter that ended in Dec. 2024 was MXN-20.69. Biomarin Pharmaceutical's Shiller PE Ratio of today is .


Biomarin Pharmaceutical E10 Historical Data

The historical data trend for Biomarin Pharmaceutical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical E10 Chart

Biomarin Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.95 -29.86 -27.20 -15.83 -20.69

Biomarin Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.83 -18.93 -18.44 -22.25 -20.69

Competitive Comparison of Biomarin Pharmaceutical's E10

For the Biotechnology subindustry, Biomarin Pharmaceutical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomarin Pharmaceutical's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomarin Pharmaceutical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biomarin Pharmaceutical's Shiller PE Ratio falls into.



Biomarin Pharmaceutical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biomarin Pharmaceutical's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=13.348/133.1571*133.1571
=13.348

Current CPI (Dec. 2024) = 133.1571.

Biomarin Pharmaceutical Quarterly Data

per share eps CPI Adj_EPS
201503 -6.555 99.621 -8.762
201506 -8.002 100.684 -10.583
201509 -10.139 100.392 -13.448
201512 6.706 99.792 8.948
201603 -8.779 100.470 -11.635
201606 -47.713 101.688 -62.479
201609 -4.254 101.861 -5.561
201612 -10.927 101.863 -14.284
201703 -1.695 102.862 -2.194
201706 -3.796 103.349 -4.891
201709 -1.270 104.136 -1.624
201712 -5.892 104.011 -7.543
201803 -4.724 105.290 -5.974
201806 -1.768 106.317 -2.214
201809 -130.935 106.507 -163.698
201812 -0.589 105.998 -0.740
201903 -6.207 107.251 -7.706
201906 -4.034 108.070 -4.970
201909 5.923 108.329 7.280
201912 1.509 108.420 1.853
202003 10.317 108.902 12.615
202006 -3.693 108.767 -4.521
202009 88.585 109.815 107.415
202012 2.387 109.897 2.892
202103 1.840 111.754 2.192
202106 1.393 114.631 1.618
202109 -4.112 115.734 -4.731
202112 -6.564 117.630 -7.430
202203 12.544 121.301 13.770
202206 3.018 125.017 3.215
202209 -0.805 125.227 -0.856
202212 -0.026 125.222 -0.028
202303 4.867 127.348 5.089
202306 4.972 128.729 5.143
202309 3.658 129.860 3.751
202312 1.867 129.419 1.921
202403 7.634 131.776 7.714
202406 10.076 132.554 10.122
202409 10.830 133.029 10.840
202412 13.348 133.157 13.348

Add all the adjusted EPS together and divide 10 will get our e10.


Biomarin Pharmaceutical  (MEX:BMRN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biomarin Pharmaceutical E10 Related Terms

Thank you for viewing the detailed overview of Biomarin Pharmaceutical's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomarin Pharmaceutical Business Description

Address
770 Lindaro Street, San Rafael, CA, USA, 94901
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.